Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients*

OBJECTIVE: To compare the efficacy and safety of two different doses of celecoxib and diclofenac in the treatment of Norwegian patients with ankylosing spondylitis. METHODS: In this 12-week, double-blind, non-inferiority trial patients were randomized to 200 mg once daily (qd) celecoxib, 400 mg qd c...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Chris, Essex, Margaret N, Li, Chunming, Park, Peter W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536700/
https://www.ncbi.nlm.nih.gov/pubmed/26980340
http://dx.doi.org/10.1177/0300060516628704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536700/
https://www.ncbi.nlm.nih.gov/pubmed/26980340
http://dx.doi.org/10.1177/0300060516628704

Ejemplares similares